Identification of residues surrounding the active site of type A botulinum neurotoxin important for substrate recognition and catalytic activity.
about
Substrate Binding Mode and Its Implication on Drug Design for Botulinum Neurotoxin AStructural Framework for Covalent Inhibition of Clostridium botulinum Neurotoxin A by Targeting Cys165Light chain separated from the rest of the type a botulinum neurotoxin molecule is the most catalytically active form.Structural insight into exosite binding and discovery of novel exosite inhibitors of botulinum neurotoxin serotype A through in silico screening.Cleavage of SNAP25 and its shorter versions by the protease domain of serotype A botulinum neurotoxin.Towards new uses of botulinum toxin as a novel therapeutic toolSystematic discovery of molecular probes targeting multiple non-orthosteric and spatially distinct sites in the botulinum neurotoxin subtype A (BoNT/A).Substrate-based inhibitors exhibiting excellent protective and therapeutic effects against Botulinum Neurotoxin A intoxicationClinical uses of botulinum neurotoxins: current indications, limitations and future developmentsThe C terminus of the catalytic domain of type A botulinum neurotoxin may facilitate product release from the active siteToxins from bacteria.Clostridial neurotoxins: mechanism of SNARE cleavage and outlook on potential substrate specificity reengineering.Tyrosine phosphorylation of botulinum neurotoxin protease domainsAugmentation of VAMP-catalytic activity of botulinum neurotoxin serotype B does not result in increased potency in physiological systems.Catalytic properties of botulinum neurotoxin subtypes A3 and A4.A novel role of C-terminus in introducing a functionally flexible structure critical for the biological activity of botulinum neurotoxin.
P2860
Q27652307-9577171A-E999-44D7-AC38-7EB23D580735Q27671266-7A8F9926-38F1-4B9E-B17A-5DED9C6EC3B9Q33705121-792CD169-D9E1-48FF-AB80-621D3302030EQ34068107-5F4EEC2C-6E2B-470A-B93C-0BCDCAF7F886Q35158088-EB030841-0EE0-475E-80A5-91A7DF284E3CQ35534477-0C8457D5-DE84-4B60-9D92-DEE91BC2F95FQ35668505-7D3344D3-29C2-4F44-BF7F-19F87E935C39Q36301587-1C7204B6-83BA-49E0-8FC8-73BBF793EFF1Q36395728-F704517E-6FAF-4633-9461-0468A56B93B0Q37099805-86BE503F-52A9-4EB8-8BC9-E9F6C8804FB9Q37722655-4363CC45-039B-4E04-AA3D-70889FA3DB43Q37954285-27CFE845-DEB6-416D-B134-4BD932C0092DQ41784019-2AF61BCB-BBD1-45B0-AC3A-3D32F3066A0EQ42370735-4B2AABAD-3365-4C7E-A83E-233BDE82B78FQ43106828-0D376DDD-9108-4FCD-8FFD-1475EECF2B88Q55414720-0BB25981-ACA3-489A-A50D-B63EAF0ED25C
P2860
Identification of residues surrounding the active site of type A botulinum neurotoxin important for substrate recognition and catalytic activity.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Identification of residues sur ...... nition and catalytic activity.
@en
Identification of residues sur ...... nition and catalytic activity.
@nl
type
label
Identification of residues sur ...... nition and catalytic activity.
@en
Identification of residues sur ...... nition and catalytic activity.
@nl
prefLabel
Identification of residues sur ...... nition and catalytic activity.
@en
Identification of residues sur ...... nition and catalytic activity.
@nl
P2093
P1433
P1476
Identification of residues sur ...... nition and catalytic activity.
@en
P2093
Janice Gilsdorf
Leonard A Smith
Mark A Olson
Matthew L Ludivico
S Ashraf Ahmed
P2860
P2888
P304
P356
10.1007/S10930-007-9118-8
P577
2008-04-01T00:00:00Z